July 18, 2019: Anal neoplasia risk amidst comorbid HPV and chlamydia; predictive modeling for PrEP outreach; long-term benefits of hepatitis C cure in coinfection; first-line therapy with dolutegravir/lamivudine.
Will potential study participants choose a vaccine trial over getting access to PrEP?
Next week, 6,000 HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.
But racial disparities persist.
On-demand pre-exposure prophylaxis may be best for people with episodic risk who cannot or would prefer not to take the pill every day.
In conservative Central Indiana, this LGBTQ-run agency transcended its repressive origins and helps people with HIV who are discriminated against at other local institutions.
In North Carolina, Greater Charlotte is booming, but income disparity, Immigration and Customs Enforcement (ICE) raids on immigrants, and spread-out service providers all create challenges to reversing HIV rates.
Caracole, an HIV/AIDS services provider in Cincinnati, has responded to a spike in HIV there by expanding harm reduction, housing, and pre-exposure prophylaxis.
"A lot of patients want to know, 'Who else is going to see this data?'" said Peter Chai of Fenway Health in Boston.
The US Preventive Services Task Force released its final ruling in *JAMA*.